Education
About Us
Working with TipRanks
Follow Us
Universe Pharmaceuticals Incorporation (UPC)
:UPC
UPC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.51 - $2,400.00
Previous CloseN/A
Volume250.22K
Average Volume (3M)31.33K
Market Cap
$1.84M
Enterprise Value-$37.45M
Total Cash (Recent Filing)$47.27M
Total Debt (Recent Filing)$7.73M
Price to Earnings (P/E)―
Beta1.20
Next Earnings
Aug 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding563,338
10 Day Avg. Volume47,681
30 Day Avg. Volume31,334
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.02
Price to Sales (P/S)0.00
P/FCF Ratio-0.44
Enterprise Value/Market Cap-20.33
Enterprise Value/Revenue-0.37
Enterprise Value/Gross Profit-6.25
Enterprise Value/Ebitda1.52
Forecast
1Y Price Target
$4.00Price Target Upside14.94% Upside
Rating ConsensusHold
Number of Analyst Covering0
Universe Pharmaceuticals News
PremiumCompany Announcements
Universe Pharmaceuticals Announces Share Consolidation
PremiumCompany Announcements
Universe Pharmaceuticals Adjourns Shareholder Meeting Due to Lack of Quorum
PremiumCompany Announcements
Universe Pharmaceuticals Adjourns Shareholder Meeting Indefinitely
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.07% Mutual Funds
6.51% Other Institutional Investors
93.49% Public Companies and
Individual Investors
UPC FAQ
What was Universe Pharmaceuticals Incorporation’s price range in the past 12 months?
Universe Pharmaceuticals Incorporation lowest stock price was $2.51 and its highest was $2400.00 in the past 12 months.
What is Universe Pharmaceuticals Incorporation’s market cap?
Universe Pharmaceuticals Incorporation’s market cap is $1.84M.
When is Universe Pharmaceuticals Incorporation’s upcoming earnings report date?
Universe Pharmaceuticals Incorporation’s upcoming earnings report date is Aug 04, 2025 which is in 13 days.
How were Universe Pharmaceuticals Incorporation’s earnings last quarter?
Currently, no data Available
Is Universe Pharmaceuticals Incorporation overvalued?
According to Wall Street analysts Universe Pharmaceuticals Incorporation’s price is currently Undervalued.
Does Universe Pharmaceuticals Incorporation pay dividends?
Universe Pharmaceuticals Incorporation does not currently pay dividends.
What is Universe Pharmaceuticals Incorporation’s EPS estimate?
Universe Pharmaceuticals Incorporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Universe Pharmaceuticals Incorporation have?
Universe Pharmaceuticals Incorporation has 563,338 shares outstanding.
What happened to Universe Pharmaceuticals Incorporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Universe Pharmaceuticals Incorporation?
Currently, no hedge funds are holding shares in UPC
Company Description
Universe Pharmaceuticals Incorporation
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.